Cunningham Lindsey UK has reached an agreement to sell its rehabilitation and absence management business, Corpore, to The Treatment Network (TTN).
Corpore was launched in 2005 and acquired some of the assets of rehabilitation provider, Kynixa, which went into administration in June 2010.
Phil McNeilage, chief executive officer (CEO) of Cunningham Lindsey UK, said: “Since its launch in 2005, we’ve successfully grown Corpore through strong client support. However, over the last nine years the demands of this very specialised market have changed and we realised that the business would be better supported if it sat within an organisation with the same core activity and market focus.
“Corpore is the perfect fit for TTN. Combining their resources will broaden their overall range of professional rehabilitation services and provide greater market opportunities for the business in the future. We will continue to use Corpore/TTN as our preferred rehabilitation provider.
“This transaction also supports our unwavering commitment to a highly focused five-year development plan, which allows us to maximise our core claims management business.”
Jonathan Cook, chairman of TTN, said: “This purchase of Corpore makes perfect sense - we already have a number of clients in common and it will expand our range of professional services into case management and occupational health. Together, Corpore and TTN will be one of the largest, privately owned providers in the rehabilitation services sector.”
Leanne Potts, head of Corpore, said: “We are really excited to be joining TTN. I believe there are numerous benefits to be gained from combining the two businesses. The expertise in Corpore when added to the specialism in TTN will produce a very compelling proposition for the market.”
Cunningham Lindsey, Europe, Corpore, TTN